Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Capital Expenditures (2016 - 2025)

Chemours (CC) has 12 years of Capital Expenditures data on record, last reported at $185.0 million in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 4725.0% year-over-year to $185.0 million; the TTM value through Dec 2025 reached $213.0 million, up 142.05%, while the annual FY2025 figure was $213.0 million, 142.05% up from the prior year.
  • Capital Expenditures reached $185.0 million in Q4 2025 per CC's latest filing, up from -$99.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $294.0 million in Q4 2023 and bottomed at -$161.0 million in Q4 2022.
  • Average Capital Expenditures over 5 years is $51.4 million, with a median of $51.0 million recorded in 2021.
  • The widest YoY moves for Capital Expenditures: up 13200.0% in 2022, down 293.98% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $83.0 million in 2021, then tumbled by 293.98% to -$161.0 million in 2022, then surged by 282.61% to $294.0 million in 2023, then crashed by 101.36% to -$4.0 million in 2024, then skyrocketed by 4725.0% to $185.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $185.0 million in Q4 2025, -$99.0 million in Q3 2025, and $43.0 million in Q2 2025.